Trial
NCT03709550
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Roswell Park Cancer Institute
Collaborators
—
Condition
Castration Levels of Testosterone
Intervention
Decitabine
Why stopped
lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-05